[1]Molodecky NA,Soon IS,Rabi DM,et al. Increasing inci?dence and prevalence of the inflammatory bowel diseases
with time,based on systematic review[J]. Gastroenterolo?gy,2012,142( 1) : 46 - 54.
[2]Ooi CJ,Fock KM,Makharia GK,et al. The Asia - Pacific
consensus on ulcerative colitis[J]. J Gastroenterol Hepa?tol. 2010,25( 3) : 453 - 468.
[3]于兰,杨云生. MicroRNAs 在消化道疾病中的作用研
究进展[J]. 解放军医学杂志,2013,38( 12) : 1026 -
1031.
[4]Mehta A,Baltimore D. MicroRNAs as regulatory elements
in immune system logic[J]. Nature Reviews Immunology,
2016,16( 5) : 279 - 294.
[5]Baek D,Villen J,Shin C,et al. The impact of microR-
NAs on protein output[J]. Nature,2008,455( 7209) :
64 - 71.
[6]Wang F,Xia J,Wang N,et al. miR - 145 Inhibits Prolif?eration and Invasion of Esophageal Squamous Cell Carcino?ma in Part by Targeting c - Myc[J]. Onkologie,2013,36
( 12) : 754 - 758.
[7]Chen YJ,Thang MW,Chan YT,et al. Global assessment of
Antrodia cinnamomea - Induced microRNA alternations in
hepatocarcinoma Cells[J]. PLoS One,2013,8 ( 12 ) :
e82751.
[8]Josse C,Bouznad N,Geurts P,et al. Identification of a
microRNA landscape targeting the PI3K/Akt signaling
pathway in inflammation - induced colorectal carcinogene?sis[J]. Am J Physiol Gastrointest Liver Physiol,2014,306
( 3) : G229 - 243.
[9]McGovern D P B,Gardet A,Trkvist L,et al. Genome -
wide association identifies multiple ulcerative colitis sus?ceptibility loci[J]. Nature genetics,2010,42 ( 4) : 332
- 337.
[10]Barrett J C,Lee J C,Lees C W,et al. Genome - wide as?sociation study of ulcerative colitis identifies three new
susceptibility loci,including the HNF4A region[J]. Na?ture genetics,2009,41( 12) : 1330 - 1334.
[11]Asano K,Matsushita T,Umeno J,et al. A genome -
wide association study identifies three new susceptibility
loci for ulcerative colitis in the Japanese population[J].
Nature genetics,2009,41( 12) : 1325 - 1329.
[12]Okubo M,Tahara T,Shibata T,et al. Association study
of common genetic variants in pre - microRNAs in pa?tients with ulcerative colitis[J]. Journal of clinical im?munology,2011,31( 1) : 69 - 73.
[13]Brase J C,Wuttig D,Kuner R,et al. Serum microRNAs
Jan. 2017 Vol. 37 No. 1
2017 年 1 月第 37 卷第 1 期 现 代 中 医 药
Modern Traditional Chinese Medicine ·85·
as non - invasive biomarkers for cancer[J]. Molecular
cancer,2010,9( 1) : 1.
[14]Gilad S,Meiri E,Yogev Y,et al. Serum microRNAs are
promising novel biomarkers[J]. PloS one,2008,3( 9) :
e3148.
[15]Zhang Y,Liu D,Chen X,et al. Secreted monocytic miR
- 150 enhances targeted endothelial cell migration[J].
Molecular cell,2010,39( 1) : 133 - 144.
[16]Arroyo J D,Chevillet J R,Kroh E M,et al. Argonaute2
complexes carry a population of circulating microRNAs
independent of vesicles in human plasma[J]. Proceedings of the National Academy of Sciences,2011,108
( 12) : 5003 - 5008.
[17]铁轶,付汉江,郑晓飞. 循环 microRNA 与肿瘤诊断
[J]. 中国科学: C 辑,2009,39( 1) : 64 - 68.
[18]Mitchell P S,Parkin R K,Kroh E M,et al. Circulating
microRNAs as stable blood - based markers for cancer
detection[J]. Proceedings of the National Academy of
Sciences,2008,105( 30) : 10513 - 10518.
[19]Valadi H,Ekstrm K,Bossios A,et al. Exosome - mediated transfer of mRNAs and microRNAs is a novel
mechanism of genetic exchange between cells[J]. Nature
cell biology,2007,9( 6) : 654 - 659.
[20]Chen X,Ba Y,Ma L,et al. Characterization of microR-
NAs in serum: a novel class of biomarkers for diagnosis
of cancer and other diseases[J]. Cell research,2008,
18( 10) : 997 - 1006.
[21]Wu F,Zi ku soka M,TrindadeA ,et al. MicroRNAs are
differentially expressed in ulcerative colitis and alter expression macrophage inflammatory peptide - 2 alpha[J].
Gastroenterology,2008,135( 5) : 1624 - 1635.
[22]Wu F,Guo NJ,Tian H,et al. Peripheral blood microR-
NAs distinguish active ulcerative colitis and Crohn’s disease[J]. Inflamm Bowel Dis,2011,17( 1) : 241 - 250.
[23]Yang Y,Ma Y,Shi C. Overexpression of miR - 21 in patients with ulcerative colitis impairs intestinal epithelial
barrier function through targeting the Rho GTPase RhoB.
Biochem Biophys Res Commun 434: 746 - 752.
[24]Paraskevi A,Theodoropoulos G,Papaconstantinou I et
al. Circulating MicroRNA in inflammatory bowel disease. J Crohns Colitis 6: 900 - 904.
[25]Fisher K,Lin J. MicroRNA in inflammatory bowel disease: Translational research and clinical implication[J].
World journal of gastroenterology, 2015, 21 ( 43 ) :
12274.
[26]Zahm A M,Hand N J,Tsoucas D M,et al. Rectal microRNAs are perturbed in pediatric inflammatory bowel
disease of the colon[J]. Journal of Crohn’s and Colitis,
2014,8( 9) : 1108 - 1117.
[27]Iborra M,Bernuzzi F,Correale C,et al. Identification of
serum and tissue micro ‐ RNA expression profiles in different stages of inflammatory bowel disease[J]. Clinical
& Experimental Immunology,2013,173 ( 2 ) : 250 -
258.
[28]Duttagupta R,DiRienzo S,Jiang R,et al. Genome -
wide maps of circulating miRNA biomarkers for ulcerative
colitis[J]. PloS one,2012,7( 2) : e31241.
[29]Wang K,Yuan Y,Cho J H,et al. Comparing the MicroRNA spectrum between serum and plasma[J]. PloS
one,2012,7( 7) : e41561.
[30]张声生,李乾构. 溃疡性结肠炎中医诊疗共识意见
[J]. 中华中医药杂志,2010,25( 6) : 891 - 895.
[31]李建华. 论痈与溃疡性结肠炎[J]. 辽宁中医药大学学
报,2010,12( 5) : 123 - 124.
[32]黄海龙,陈刚. 中西医结合对溃疡性结肠炎血瘀证的
研究现状[J]. 中国中西医结合消化杂志,2011,19( 5) : 342 - 344.
[33]徐阳. 初探溃疡性结肠炎发病因素与痰瘀相关的回顾
性研究[D]. 沈阳: 辽宁中医药大学,2013.
[34]许清华,郝会莲,毛艳,等. 从虚论治慢性溃疡性结肠
炎[J]. 西部中医药,2011,24( 12) : 100 - 102.
[35]李军. 基于“脏腑风湿”理论的溃疡性结肠炎从痹辨治
思路[J]. 江苏中医药,2014,46( 3) : 8 - 10.
[36]李倩,周铭心. 基于二次文献的溃疡性结肠炎证候分
析[J]. 中华中医药杂志,2014,29( 4) : 1236 - 1239.
[37]张家仕. miRNA - 499 与冠心病中医证型的相关性研
究[D]. 广州: 广州中医药大学,2014.
[38]冯知涛. RA 患者外周血 miR - 146a、miR - 16 表达与
疾病活动、中医证型相关性及青藤碱制剂对其干预的
研究[D]. 深圳: 南方医科大学,2011.
[39]袁雅琪. 干燥综合征阴虚证患者中 miR - 17 - 92 的
表达与临床谱及中医证型的相关性研究[D]. 南京:
南京中医药大学,2014.
[40]原宁. 结直肠腺瘤中医虚实证候 miRNA 表达谱的研
究[D]. 广州: 广州中医药大学,2012.
收稿日期:2016-05-08编辑:巩振东***
基金项目:国家自然科学基金(编号:81173156);陕西省自然科学基础研究计划(2012JM4017)
通讯作者:杨晓航(1974-),男,硕士研究生导师,副教授,研究方向:中医药免疫调节作用机制研究,E-mail:
yxh1.0@163.com